Physician profile
Julia Macchiaroli
NPI 1821057852
$2,492.74
in general payments reported to CMS, 2019-2025
30 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $329 · 2022: $955 · 2023: $288 · 2024: $721 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $657.57 | 2021-2024 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $317.68 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $170.59 | 2021-2025 | Wegovy |
| Abbott Laboratories | $144.96 | 2023-2025 | Freestyle Libre 3 |
| Kaleo, INC. | $135.79 | 2022-2024 | Auvi-Q |
| Insulet Corporation | $124.05 | 2021-2024 | Omnipod |
| Regeneron Healthcare Solutions, INC. | $108.17 | 2024-2025 | Dupixent |
| Xeris Pharmaceuticals, INC. | $88.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $82.44 | 2021-2024 | Farxiga |
| Medtronic, INC. | $72.51 | 2022-2024 | Linq II, Venaseal |
| Dexcom, INC. | $66.02 | 2022 | |
| Corcept Therapeutics | $63.92 | 2021-2024 | Korlym |
| Novartis Pharmaceuticals Corporation | $49.46 | 2024-2025 | |
| Amryt Pharma Holdings LTD | $44.40 | 2022 | |
| Amneal Pharmaceuticals LLC | $36.93 | 2022-2025 | Unithroid |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $32.63 | 2023 | Hillrom - Life 2000 Ventilation System |
| Bayer Healthcare Pharmaceuticals INC. | $29.45 | 2024 | |
| Electromed, INC. | $28.12 | 2023 | Smartvest |
| Heartflow, INC. | $27.82 | 2025 | |
| Renalytix Ai, INC. | $24.40 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Otsuka America Pharmaceutical, INC. | $20.69 | 2024 | Rexulti |
| Exact Sciences Corporation | $20.20 | 2023 | Cologuard Collection Kit |
| Clarus Therapeutics INC. | $20.06 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.86 | 2023 | Xarelto |
| Phadia US INC. | $19.64 | 2024 | Immunocap |
| Atricure, INC. | $19.13 | 2023 | |
| Solventum Corporation | $19.09 | 2024 | Activ.A.C. |
| Actelion Pharmaceuticals US, INC. | $18.06 | 2024 | Opsumit, Uptravi |
| Tandem Diabetes Care, INC. | $16.28 | 2022 | |
| Advanced Oxygen Therapy INC. | $14.48 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Macchiaroli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.